TEC H NO LO G Y
The Future of
Brain Based Healthcare
Private Placement Memorandum
For More Information Visit: NexalinTechnology.com
© 2015 NEXALIN TECHNOLOGY, INC. ALL RIGHTS RESERVED.
NEXALIN TECHNOLOGY, INC.
CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM
Twenty Eight Million Five Hundred Thousand Dollars
(For Accredited Investors Only)
Nexalin Technology, Inc. (“We”, “Us”, “Company”, “Nexalin Technology” or “Nexalin”) is a Nevada company
formed October 19, 2010 for the purpose of acquiring the worldwide distribution rights to Nexalin® Therapy
including any future delivery platforms or devices for the treatment of Anxiety, Depression and Insomnia (ADI) in
the United States and other treatment therapies including Chronic Pain, Parkinson’s Disease and Musculoskeletal
treatments in international markets from Spiritus Group, Inc. (“Spiritus”). The Company hereby offers a maximum
of Five Million Five Hundred Thousand Shares (“Shares”) at pu